Rikki Hammel
Nurse Practitioner · Manitowoc, WINPI 1790096832
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,328 of the $10,322 with a category attached, or 71.0%. 25 manufacturers reported payments, led by UCB, Inc. at 29.3% of the total. Reporting peaked in 2022 at $4,324 and has fallen 99.4% since, to $27 in 2025. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 504 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- AbbVie$1K
- Johnson & Johnson$1K
- Regeneron Healthcare Solutions, Inc.$819
- Sun Pharmaceutical Industries Inc.$688
- Sanofi$461
- plus $3K from 19 others
What the payments were for
- Consulting fees$2,79527%
- Food & beverage$7,32871%
- Education$1992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 12 | $3,026 |
| AbbVie(2 entities) | 99 | $1,410 |
| Johnson & Johnson | 90 | $1,308 |
| Regeneron Healthcare Solutions, Inc. | 33 | $819 |
| Sun Pharmaceutical Industries Inc. | 59 | $688 |
| Sanofi | 27 | $461 |
| Novartis | 33 | $459 |
| Lilly USA, LLC | 40 | $451 |
| Pfizer | 39 | $381 |
| E.r. Squibb & Sons, L.L.C. | 15 | $256 |
| Amgen | 16 | $232 |
| Incyte Corporation | 7 | $144 |
| Dermavant Sciences, Inc. | 7 | $138 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| VYNE Pharmaceuticals Inc. | 3 | $72 |
| Dermira, Inc. | 3 | $66 |
| Galderma Laboratories, L.p. | 4 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $58 |
| Genentech USA, Inc. | 3 | $51 |
| Biofrontera Inc. | 3 | $44 |
| Boehringer Ingelheim | 2 | $33 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $30 |
| Organogenesis Inc. | 1 | $21 |
| Journey Medical Corporation | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $17 |
How this compares
$10,322 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 26 | $435 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Manitowoc
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Nicole BarteltWaukesha$85K
- Kari FisherPrairie du Sac$57K
- Roxanne RadichAppleton$54K
- Kelly FlugaurMilwaukee$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.